About Us | Contact Us |        
ActivityTopicFaculty ChairLaunch DateCreditExpiration Date
Cardiology
Navigating the Challenges of Prescribing PCSK9 Inhibitors in Patients with Persistent Elevated...
icon_615795.jpgExperts in the Hot Seat: Navigating PCSK9 Inhibitor Prescribing in Persistent Elevated LDL-CCardiologyWinston Wong, PharmD18-Jan-181.25 AMA
1.25 ACPE
1.3 ANCC
1 CDR
18-Jan-19615795riq_608060Navigating the Challenges of Prescribing PCSK9 Inhibitors in Patients with Persistent Elevated...5
icon_598568.jpgNavigating the Challenges of Prescribing PCSK9 Inhibitors in Patients with Persistent Elevated LDL-CCardiologyJames Underberg, MS, MD, FACPM, FACP, FASH, FASPC, FNLA (Chair)19-Sep-171 AMA
1 ACPE
1 ANCC
1 CDR
19-Sep-18598568The use of PCSK9 inhibitors (PSCK9Is) in certain patients with hypercholesterolemiariq_608060Navigating the Challenges of Prescribing PCSK9 Inhibitors in Patients with Persistent Elevated...5
Dermatology
Individualizing Treatment for Patients with Psoriatic Disease: Optimizing Quality of Life and...
icon_585059.pngImproving the Psoriatic Disease ContinuumDermatologyLeonard H. Calabrese, DO29-Jun-170.5 AMA
28-Jun-18585059riq_595399Individualizing Treatment for Patients with Psoriatic Disease: Optimizing Quality of Life and...5
icon_584667.pngMissed Opportunities in Managing Patients with Psoriatic DiseaseDermatologyLeonard H. Calabrese, DO29-Jun-170.75 AMA
28-Jun-18584667This activity utilizes a question-and-answer format to review the clinical evidence as well as guideline recommendations for the riq_595400Individualizing Treatment for Patients with Psoriatic Disease: Optimizing Quality of Life and...5
Endocrinology
Evolving Paradigms for Insulin Therapy of Type 2 Diabetes
icon_599950.jpgCase Challenges in the Use of Insulin in T2DMEndocrinologyLouis H. Philipson, MD, PhD07-Dec-170.75 AMA
07-Dec-18599950This activity uses interactive case scenarios to examine challenges in the management of T2DM.riq_615990Evolving Paradigms for Insulin Therapy of Type 2 Diabetes5
icon_599849.jpgManagement of T2DM: The Role of InsulinEndocrinologyLouis H. Philipson, MD, PhD21-Nov-170.75 AMA
21-Nov-18599849This activity examines challenges encountered in the management of T2DM and the many therapeutic options available to clinicians.riq_615990Evolving Paradigms for Insulin Therapy of Type 2 Diabetes5
icon_620638.jpgTeam-based Care for Patients with Type 2 DiabetesEndocrinologyNeda Laiteerapong, MD, MS, FACP21-Dec-171 AMA
1 CDR
21-Dec-18620638This activity employs a multidisciplinary panel to examine the various clinical roles in the management of T2DM.riq_615990Evolving Paradigms for Insulin Therapy of Type 2 Diabetes5
Integrating Data on Macrovascular and Microvascular Outcomes into Diabetes Management
icon_607280.jpgIntegrating Data on Macrovascular and Microvascular Outcomes in Diabetes: Evolving Treatment StrategiesEndocrinologyLuigi Meneghini, MD, MBA12-Oct-171 AMA
1 AANP
11-Oct-18607280riq_612619Integrating Data on Macrovascular and Microvascular Outcomes into Diabetes Management5
Nephrology
Hyperkalemia and Health Outcomes
icon_499596.pngHyperkalemia and Health Outcomes: A vClinic.org HFSA Symposium Highlights - Part 1NephrologyMurray Epstein, MD, FSACP, FSN05-Apr-161 AMA
1 ANCC
04-Apr-18499596riq_484783Hyperkalemia and Health Outcomes5
icon_508906.pngHyperkalemia and Health Outcomes: A vClinic.org HFSA Symposium Highlights - Part 2NephrologyMurray Epstein, MD, FSACP, FSN07-Apr-161 AMA
1 ANCC
06-Apr-18508906riq_484783Hyperkalemia and Health Outcomes5
icon_507667.jpgHyperkalemia and Heart Failure: A Case Vignette ProgramNephrologyBarry Greenberg, MD22-Mar-161 AMA
1 ANCC
21-Mar-18507667riq_484783Hyperkalemia and Health Outcomes5
icon_504636.jpgHyperkalemia and Heart Failure: A vClinic.org Mastery Assessment ProgramNephrologyBarry Greenberg, MD29-Mar-161 AMA
1 ANCC
28-Mar-18504636riq_484783Hyperkalemia and Health Outcomes5
Neurology
Modern Migraine Management
icon_519120.jpgMigraine Masters Part III: Meet the Migraine Patient - a vClinic.org programNeurologyBrian D. Loftus, MD07-Jul-161.5 AMA
1.5 ANCC
06-Jul-18519120riq_516305Modern Migraine Management5
icon_515146.jpgMigraine Masters: Part II: Pharmacology - a vClinic.org programNeurologyStephen Landy, MD09-Jun-161.5 AMA
1.5 ANCC
08-Jun-18515146Migraine Mastersriq_516305Modern Migraine Management5
MigraineMastersCourseIcon.jpgMigraine Masters Part I: The Fundamentals - a vClinic.org ProgramNeurologyRebecca Burch, MD12-May-161.5 AMA
1.5 ANCC
11-May-18508287Migraine Mastersriq_516305Modern Migraine Management5
Oncology
Non-Small Cell Lung Cancer: Optimizing Systemic Therapy Options Beyond the 1st Line
icon_608408.jpgNon-Small Cell Lung Cancer: Optimizing Systemic Therapy Options Beyond the 1st LineOncologyMark A. Socinski, MD30-Jan-180.5 AMA
0.5 ANCC
30-Jan-19608408This activity will cover the treatment and management of patients with Non-Small Cells Lung Cancer.riq_619851Non-Small Cell Lung Cancer: Optimizing Systemic Therapy Options Beyond the 1st Line5
Outcomes in NSCLC: A Focus on Quality Improvement
icon_581867.jpgOutcomes in NSCLC: A Focus on Quality Improvement - Part 1OncologyThomas E. Stinchcombe, MD27-Apr-171.25 AMA
27-Apr-18581867riq_588760Outcomes in NSCLC: A Focus on Quality Improvement5
icon_594967.jpgOutcomes in NSCLC: A Focus on Quality Improvement - Part 2OncologyThomas E. Stinchcombe, MD29-Aug-171.25 AMA
29-Aug-18594967riq_588760Outcomes in NSCLC: A Focus on Quality Improvement5
icon_611973.jpgSustaining Change in Quality Improvement for NSCLC - Part 3OncologyThomas E. Stinchcombe, MD21-Dec-171.25 AMA
21-Dec-18611973riq_588760Outcomes in NSCLC: A Focus on Quality Improvement5
Targeting Molecular Mechanisms in Patients with Metastatic Breast Cancer: Inhibiting Estrogen...
icon_609943.jpgTargeting Molecular Mechanisms in Patients with Metastatic Breast Cancer: Inhibiting Estrogen Receptor-Induced ProliferationOncologyJoyce O'Shaughnessy, MD28-Dec-171 AMA
1 ANCC
28-Dec-18609943This activity will cover the treatment and management of patients with Metastatic Breast Cancer.riq_620481Targeting Molecular Mechanisms in Patients with Metastatic Breast Cancer: Inhibiting Estrogen...5
Psychiatry
Derail Depression -- Treatment On Track
icon_535229.jpgA Collaborative Care Approach to Managing Depression in Primary CarePsychiatryMichael Clark, MD05-Sep-170.5 AMA
04-Sep-19535229riq_559632Derail Depression -- Treatment On Track5
icon_535359.jpgChallenges in the Primary Care of Depression: A Patient Huddle ActivityPsychiatryMichael Clark, MD14-Sep-170.5 AMA
13-Sep-19535359riq_559632Derail Depression -- Treatment On Track5
Rheumatology
A Guideline-Driven Approach to RA: Disease Monitoring, Treatment Selection, and Patient...
icon_586337.jpgA Guideline-Driven Approach to RA: Disease Monitoring, Treatment Selection, and Patient PreferenceRheumatologyJeffrey R. Curtis, MD, MS, MPH02-May-171 AMA
02-May-18586337riq_588702A Guideline-Driven Approach to RA: Disease Monitoring, Treatment Selection, and Patient...5
Rheumatoid Arthritis: The Importance of Early Diagnosis and Timely Access to Treatment
icon_623555.pngEffective Practice Strategies to Achieve Earlier RA Diagnosis and Faster Initiation of CareRheumatologyIain B. McInnes, MD, PhD28-Dec-170.5 AMA
27-Dec-18623555riq_623387Rheumatoid Arthritis: The Importance of Early Diagnosis and Timely Access to Treatment5
icon_622323.pngThe Impact of Earlier Diagnosis and Timelier Treatment of Rheumatoid Arthritis on Patient Outcomes and Healthcare SystemsRheumatologyMarc D. Cohen, MD28-Dec-170.5 AMA
27-Dec-18622323Assess your ability to diagnose and manage early rheumatoid arthritis; hear a discussion of practice strategies from an expert panel. riq_623387Rheumatoid Arthritis: The Importance of Early Diagnosis and Timely Access to Treatment5
Tailoring Approaches to Management in Patients with RA: What’s New?
icon_587305.jpgNovel Personalized Management Approaches in Rheumatoid ArthritisRheumatologyVibeke Strand, MD, MACR, FACP16-May-170.5 AMA
16-May-18587305Recent updates to the ACR guidelines riq_571768Tailoring Approaches to Management in Patients with RA: What’s New?5
Treating the Underlying Cause of Gout in Primary Care to Prevent Acute Attacks
icon_623713.pngA New Look at Gout: A Chronic, Systemic, Inflammatory - and Curable - DiseaseRheumatologyBrian F. Mandell, MD, PhD04-Jan-181 AMA
1 ANCC
04-Jan-19623713A leading expert explains how gout can be cured, and flares prevented, through appropriate use of medications and lifestyle changes.riq_624476Treating the Underlying Cause of Gout in Primary Care to Prevent Acute Attacks5
icon_626233.pngFrom Science to Practice - Gout Case Study in Primary CareRheumatologyBrian F. Mandell, MD, PhD31-Jan-181 AMA
1 ANCC
30-Jan-19626233Gout can be prevented -- and cured. Explore this challenging case study and see how your approach compares to that of your peers..riq_624476Treating the Underlying Cause of Gout in Primary Care to Prevent Acute Attacks5
Urology
Teaching through a Window: Optimal Management of Advanced Prostate Cancer in a Urology Practice
icon_607818.jpgDelivering Advanced Prostate Cancer Therapy in a Virtual Urology ClinicUrologyDavid M. Albala, MD28-Sep-171 AMA
28-Sep-18607818Experience managing prostate cancer pts in a virtual urology practice. Challenge questions, mgmt approaches and peer benchmarking included.riq_604982Teaching through a Window: Optimal Management of Advanced Prostate Cancer in a Urology Practice5
icon_595941.jpgManaging Advanced Prostate Cancer in a Virtual Urology ClinicUrologyNeal Shore, MD, FACS07-Sep-171 AMA
07-Sep-18595941Experience managing prostate cancer pts in a virtual urology practice. Challenge questions, mgmt approaches and peer benchmarking included.riq_604982Teaching through a Window: Optimal Management of Advanced Prostate Cancer in a Urology Practice5